CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Biotech
Original article

Ascidian Therapeutics Announces Leadership Transition

Neutral
AI Analysis

Summary

Ascidian Therapeutics announced a planned leadership transition with Daniel Rosan appointed as President, while Michael Ehlers continues as Board Chair.

Importance:2/10
Sentiment:
0.00
leadership transitionmanagement changeRNA therapeutics

Read the original article

Published by PR Newswire Biotech on July 21, 2026 8:30 PM

Read Original